StockData
ADARx Pharmaceuticals, Inc. logo

ADARx Pharmaceuticals, Inc. (ADRX) bonds

ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$13.82−0.18 (-1.29%)

Close on Nov 17, 2026Market cap $1.48BP/E –Yield –

Debt

Borrowings on the balance sheet

ADARx Pharmaceuticals reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

Individual notes, bonds and loans

ADARx Pharmaceuticals's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

See a number that looks wrong?